Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients

Duygu Selcen1, Kinji Ohno, Andrew G Engel

  • 1Department of Neurology, Neuromuscular Research Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Selcen.Duygu@mayo.edu

Insights

Myofibrillar myopathy (MFM) is a muscle disorder characterized by myofibrillar dissolution. Genetic analysis reveals it is morphologically distinct but genetically heterogeneous, with mutations found in desmin and alphaB-crystallin.

Area of Science:

  • Neurology
  • Pathology
  • Genetics

Background:

  • Myofibrillar myopathy (MFM) is a pathological pattern of myofibrillar dissolution with protein accumulation.
  • Previous studies identified dominant mutations in desmin and alphaB-crystallin (alphaBC) in some MFM patients.
  • MFM presents with diverse clinical manifestations and varying genetic underpinnings.

Purpose of the Study:

  • To review the clinical, structural, and genetic features of 63 unrelated MFM patients.
  • To identify common diagnostic markers and underlying genetic causes of MFM.
  • To explore the relationship between MFM subtypes and specific protein abnormalities.

Main Methods:

  • Retrospective review of clinical data, muscle biopsies, and genetic analyses from 63 MFM patients (1977-2003).
  • Histopathological examination using trichrome staining and immunohistochemistry for desmin, alphaBC, myotilin, dystrophin, and beta-amyloid precursor protein.
  • Genetic analysis for mutations in desmin, alphaBC, telethonin, and syncoilin.

Main Results:

  • Average age of onset was 54 years, with 77% experiencing proximal and distal weakness.
  • Muscle fibers showed amorphous hyaline structures and vacuoles; 90% overexpressed myotilin.
  • Genetic analysis identified mutations in alphaBC (2 patients) and desmin (4 patients), confirming genetic heterogeneity.

Conclusions:

  • Myofibrillar myopathy is morphologically distinct but genetically heterogeneous.
  • Immunohistochemistry for myotilin, desmin, and alphaBC aids in MFM diagnosis.
  • Further research into Z-disk proteins is needed to elucidate the molecular causes of MFM.

Related Concept Videos

Types of Intermediate Filaments01:31

Types of Intermediate Filaments

The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...
Classification of Skeletal Muscle Fibers01:48

Classification of Skeletal Muscle Fibers

Skeletal muscles continuously produce ATP to provide the energy that enables muscle contractions. Skeletal muscle fibers can be categorized into three types based on differences in their contraction speed and how they produce ATP, as well as physical differences related to these factors. Most human muscles contain all three muscle fiber types, albeit in varying proportions.
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...